Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. | Academic Article |
Why?
|
Morphea and its variants and the "floating sign"-an additional finding in morphea. | Academic Article |
Why?
|
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib. | Academic Article |
Why?
|
Morphea-like tattoo reaction. | Academic Article |
Why?
|
Scleroderma, Localized | Concept |
Why?
|
Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis. | Academic Article |
Why?
|
Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature. | Academic Article |
Why?
|
Morphea | Academic Article |
Why?
|
Falanga, Vincent | Person |
Why?
|
A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis. | Academic Article |
Why?
|
Acute lipodermatosclerosis is associated with venous insufficiency. | Academic Article |
Why?
|
Alopecia with perineural lymphocytes: a clue to linear scleroderma en coup de sabre. | Academic Article |
Why?
|
Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits. | Academic Article |
Why?
|
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. | Academic Article |
Why?
|
D-penicillamine in the treatment of localized scleroderma. | Academic Article |
Why?
|